1.Effect of interaction between ADIPOQ gene 11377C/G polymorphism and physical activity on metabolic syndrome in children
Kaifeng WANG ; Ping YE ; Dan WANG ; Liufeng WU ; Weijia LIU ; Qing CHEN ; Jiandong LI
The Journal of Practical Medicine 2015;31(23):3853-3856
Objectve To study the effect of interaction between ADIPOQ 11377C/G (rs266729) gene polymorphism and physical activity in metabolic syndrome in children. Methods We conducted a case-control study in 114 cases and 114 controls. The genotype of ADIPOQ 11377C/G had been detected in direct sequenc-ing. The effect of interaction between gene polymorphism and physical activity was evaluated by a crossover analysis. Results Efficient physical activity was a protective factor (OR = 0.14); there was interaction between inefficient physical activity and CC genotype of 11377C/G which was a risk factor for metabolic syndrome in children. Conclusion Efficient physical activity can reduce the risk of metabolic syndrome in children. There was interaction between 11377C/G (rs266729) polymorphism and physical activity.
2.Characteristics and influencing factors of immune-related adverse events in patients with extensive-stage small cell lung cancer treated with immune checkpoint inhibitors
Qiong WU ; Qichun HUANG ; Zhongyu QIN ; Liufeng LIAO
China Pharmacy 2024;35(22):2784-2788
OBJECTIVE To explore the clinical characteristics and influencing factors of immune-related adverse events (irAEs) in patients with extensive-stage small cell lung cancer (SCLC) treated with immune checkpoint inhibitors (ICIs). METHODS The data from 130 patients with extensive-stage SCLC treated with ICIs at our hospital from January 1, 2023, to May 31, 2023 was collected retrospectively using the Chinese Hospital Pharmacovigilance System. The occurrence of irAEs and the use of corticosteroids during treatment for all patients were recorded. A multifactorial Logistic regression model was used to analyze the influencing factors for the occurrence of irAEs. RESULTS Among the 130 patients included, 32 patients experienced 38 episodes of irAEs, with an incidence rate of 24.6% and severity of degree 1-3. Skin symptoms were the most common (8.4%) and predominantly occurred in the first cycle of treatment. Five patients developed irAEs involving multiple organ systems. The irrational use rate of corticosteroids in patients with irAEs was 23.1% (excluding patients with thyroid dysfunction). Neuron specific enolase (NSE) was a independent factor influencing the occurrence of irAEs (P<0.05). CONCLUSIONS The incidence of irAEs caused by ICIs remains relatively high and can involve various organ systems throughout the body, with skin symptoms occurring earliest. NSE is an independent influencing factor for the occurrence of irAEs, and could predict the risk of irAEs to a certain extent.